The American Association of Equine Practitioners (AAEP) recently published its Equine Viral Hepatitis Guidelines to provide ...

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen ... Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for MSI-H/dMMR colorectal cancer.

Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US. From today, the ...

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars ...

Feb. 25, 2025 — Hormones may be leveraged to treat and prevent signs of aging such as wrinkles and hair graying, according to a new ...

A NEW study suggests that reduced glutathione, when combined with standard entecavir therapy, can significantly improve liver function, reduce fibrosis, and enhance HBV-DNA clearance in patients with ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV ... found little natural resistance to a new HIV therapy called lenacapavir in a population ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.